More than Nutrition: Therapeutic Potential of Breast Milk-Derived Exosomes in Cancer

Human breast milk (HBM) is an irreplaceable source of nutrition for early infant growth and development. Breast-fed children are known to have a low prevalence and reduced risk of various diseases, such as necrotizing enterocolitis, gastroenteritis, acute lymphocytic leukemia, and acute myeloid leuk...

Full description

Bibliographic Details
Main Authors: Ki-Uk Kim, Wan-Hoon Kim, Chi Hwan Jeong, Dae Yong Yi, Hyeyoung Min
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/19/7327
_version_ 1797551850997678080
author Ki-Uk Kim
Wan-Hoon Kim
Chi Hwan Jeong
Dae Yong Yi
Hyeyoung Min
author_facet Ki-Uk Kim
Wan-Hoon Kim
Chi Hwan Jeong
Dae Yong Yi
Hyeyoung Min
author_sort Ki-Uk Kim
collection DOAJ
description Human breast milk (HBM) is an irreplaceable source of nutrition for early infant growth and development. Breast-fed children are known to have a low prevalence and reduced risk of various diseases, such as necrotizing enterocolitis, gastroenteritis, acute lymphocytic leukemia, and acute myeloid leukemia. In recent years, HBM has been found to contain a microbiome, extracellular vesicles or exosomes, and microRNAs, as well as nutritional components and non-nutritional proteins, including immunoregulatory proteins, hormones, and growth factors. Especially, the milk-derived exosomes exert various physiological and therapeutic function in cell proliferation, inflammation, immunomodulation, and cancer, which are mainly attributed to their cargo molecules such as proteins and microRNAs. The exosomal miRNAs are protected from enzymatic digestion and acidic conditions, and play a critical role in immune regulation and cancer. In addition, the milk-derived exosomes are developed as drug carriers for delivering small molecules and siRNA to tumor sites. In this review, we examined the various components of HBM and their therapeutic potential, in particular of exosomes and microRNAs, towards cancer.
first_indexed 2024-03-10T15:50:56Z
format Article
id doaj.art-a823f90175a1415fab58e2b34a0c8b47
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T15:50:56Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a823f90175a1415fab58e2b34a0c8b472023-11-20T16:01:42ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-10-012119732710.3390/ijms21197327More than Nutrition: Therapeutic Potential of Breast Milk-Derived Exosomes in CancerKi-Uk Kim0Wan-Hoon Kim1Chi Hwan Jeong2Dae Yong Yi3Hyeyoung Min4College of Pharmacy, Chung-Ang University, Seoul 06974, KoreaCollege of Pharmacy, Chung-Ang University, Seoul 06974, KoreaCollege of Pharmacy, Chung-Ang University, Seoul 06974, KoreaDepartment of Pediatrics, Chung-Ang University College of Medicine, Seoul 06974, KoreaCollege of Pharmacy, Chung-Ang University, Seoul 06974, KoreaHuman breast milk (HBM) is an irreplaceable source of nutrition for early infant growth and development. Breast-fed children are known to have a low prevalence and reduced risk of various diseases, such as necrotizing enterocolitis, gastroenteritis, acute lymphocytic leukemia, and acute myeloid leukemia. In recent years, HBM has been found to contain a microbiome, extracellular vesicles or exosomes, and microRNAs, as well as nutritional components and non-nutritional proteins, including immunoregulatory proteins, hormones, and growth factors. Especially, the milk-derived exosomes exert various physiological and therapeutic function in cell proliferation, inflammation, immunomodulation, and cancer, which are mainly attributed to their cargo molecules such as proteins and microRNAs. The exosomal miRNAs are protected from enzymatic digestion and acidic conditions, and play a critical role in immune regulation and cancer. In addition, the milk-derived exosomes are developed as drug carriers for delivering small molecules and siRNA to tumor sites. In this review, we examined the various components of HBM and their therapeutic potential, in particular of exosomes and microRNAs, towards cancer.https://www.mdpi.com/1422-0067/21/19/7327human milknutrientmicrobiotaexosomesmicroRNAscancer
spellingShingle Ki-Uk Kim
Wan-Hoon Kim
Chi Hwan Jeong
Dae Yong Yi
Hyeyoung Min
More than Nutrition: Therapeutic Potential of Breast Milk-Derived Exosomes in Cancer
International Journal of Molecular Sciences
human milk
nutrient
microbiota
exosomes
microRNAs
cancer
title More than Nutrition: Therapeutic Potential of Breast Milk-Derived Exosomes in Cancer
title_full More than Nutrition: Therapeutic Potential of Breast Milk-Derived Exosomes in Cancer
title_fullStr More than Nutrition: Therapeutic Potential of Breast Milk-Derived Exosomes in Cancer
title_full_unstemmed More than Nutrition: Therapeutic Potential of Breast Milk-Derived Exosomes in Cancer
title_short More than Nutrition: Therapeutic Potential of Breast Milk-Derived Exosomes in Cancer
title_sort more than nutrition therapeutic potential of breast milk derived exosomes in cancer
topic human milk
nutrient
microbiota
exosomes
microRNAs
cancer
url https://www.mdpi.com/1422-0067/21/19/7327
work_keys_str_mv AT kiukkim morethannutritiontherapeuticpotentialofbreastmilkderivedexosomesincancer
AT wanhoonkim morethannutritiontherapeuticpotentialofbreastmilkderivedexosomesincancer
AT chihwanjeong morethannutritiontherapeuticpotentialofbreastmilkderivedexosomesincancer
AT daeyongyi morethannutritiontherapeuticpotentialofbreastmilkderivedexosomesincancer
AT hyeyoungmin morethannutritiontherapeuticpotentialofbreastmilkderivedexosomesincancer